Skip to main content

Table 1 Tumor maker levels and coagulation tests

From: A case of Trousseau’s syndrome due to intrahepatic cholangiocarcinoma with an extremely high level of CA19-9

[normal range]

Pre-operative TMs and CTs

TMs and CTs at POW4

CA19-9 (U/mL) [0.0-37.0]

>12,0000

4905.5

CEA (ng/mL) [0.0-5.0]

589.6

6.3

CA125 (U/mL) [0.0-35.0]

64.8

104.8

CA15-3 (U/mL) [0.0-31.3]

95.4

15.3

SLX (U/mL) [0.0-38.0]

330

46

D-dimer (mg/mL) [0.0-1.0]

6.2

3.2

FDP (mg/mL) [0.0-4.9]

8.5

6.2

fibrinogen (mg/dL) [200-400]

438

272

  1. TM tumor maker, CT coagulation test, POW4 postoperative week 4, CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, CA125 cancer antigen 125, CA15-3 Cancer antigen 15-3, SLX Sialyl Lewis X, FDP fibrin degradation product